FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1356311000001107: Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24456501000001116 Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
76637901000001114 Motens 4mg tablets (GlaxoSmithKline UK Ltd) 14 tablet 2 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Is a Lacidipine 4mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Is pack of Motens 4mg tablets (Boehringer Ingelheim Ltd) false Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has active ingredient Lacidipine false Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has AMP Motens 4mg tablets (Boehringer Ingelheim Ltd) true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has specific active ingredient Lacidipine true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Motens 4mg tablets (Boehringer Ingelheim Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start